Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy
Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy have?
Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy has 99 citations in the OpenAlex counts ScholarIQ stores.
When was Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy published?
Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy has 2018 year in the ScholarIQ index.
What is the open-access status of Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy?
Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy has closed oa status in the ScholarIQ index.
What is the DOI of Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy?
The DOI for Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy is on the source record.
What is the PMID of Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy?
The PMID for Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy is on the source record.
What is the OpenAlex record for Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy?
The OpenAlex for Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy is on the source record.